115 related articles for article (PubMed ID: 38133666)
1. Immunotherapy in rectal cancer patients-a propensity score matched analysis of the National Cancer Database.
Horesh N; Emile SH; Freund MR; Garoufalia Z; Gefen R; Nagarajan A; Wexner SD
Int J Colorectal Dis; 2023 Dec; 39(1):8. PubMed ID: 38133666
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy in Stage III-IV Colon Cancer: A Propensity Score-Matched Analysis of the National Cancer Database.
Horesh N; Emile SH; Garoufalia Z; Gefen R; Zhou P; Nagarajan A; Wexner SD
J Immunother; 2024 Apr; ():. PubMed ID: 38638079
[TBL] [Abstract][Full Text] [Related]
3. The effect of primary tumor radiotherapy in patients with Unresectable stage IV Rectal or Rectosigmoid Cancer: a propensity score matching analysis for survival.
Wang G; Wang W; Jin H; Dong H; Chen W; Li X; Li G; Li L
Radiat Oncol; 2020 May; 15(1):126. PubMed ID: 32460810
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
[TBL] [Abstract][Full Text] [Related]
5. Duration of chemotherapy prior to chemoradiation affects survival outcomes for resected stage I-II or unresected stage III pancreatic cancer.
Ma SJ; Iovoli AJ; Hermann GM; Prezzano KM; Singh AK
Cancer Med; 2019 Aug; 8(9):4110-4123. PubMed ID: 31183965
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of the Microsatellite Instability Status in Patients With Stage II/III Rectal Cancer Following Upfront Surgery.
Oh CR; Kim JE; Kang J; Kim SY; Kim KP; Hong YS; Lim SB; Yu CS; Kim JC; Kim J; Jang SJ; Kim TW
Clin Colorectal Cancer; 2018 Dec; 17(4):e679-e685. PubMed ID: 30077598
[TBL] [Abstract][Full Text] [Related]
7. The Prognostic Impact of Microsatellite Instability on the Outcome of Appendiceal Adenocarcinoma: a National Cancer Database Analysis.
Emile SH; Horesh N; Garoufalia Z; Gefen R; Zhou P; Wexner SD
J Gastrointest Surg; 2023 Feb; 27(2):354-362. PubMed ID: 36650414
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Relevance of Mucinous Subtype in a Population-based Propensity Score Analysis of 40,083 Rectal Cancer Patients.
Tarantino I; Hüttner FJ; Warschkow R; Schmied BM; Diener MK; Ulrich A
Ann Surg Oncol; 2016 May; 23(5):1576-86. PubMed ID: 26714956
[TBL] [Abstract][Full Text] [Related]
9. Trends in the Characteristics, Treatment, and Outcomes of Rectal Adenocarcinoma in the US From 2004 to 2019: A National Cancer Database Analysis.
Emile SH; Horesh N; Freund MR; Garoufalia Z; Gefen R; Silva-Alvarenga E; Maron DJ; DaSilva G; Wexner SD
JAMA Oncol; 2023 Mar; 9(3):355-364. PubMed ID: 36580307
[TBL] [Abstract][Full Text] [Related]
10. Oncologic outcomes for low rectal adenocarcinoma following low anterior resection with coloanal anastomosis versus abdominoperineal resection: a National Cancer Database propensity matched analysis.
Fields AC; Scully RE; Saadat LV; Lu P; Davids JS; Bleday R; Goldberg JE; Melnitchouk N
Int J Colorectal Dis; 2019 May; 34(5):843-848. PubMed ID: 30790033
[TBL] [Abstract][Full Text] [Related]
11. No benefit after neoadjuvant chemoradiation in stage IV rectal cancer: A propensity score-matched analysis on a real-world population.
Milito P; Sorrentino L; Pietrantonio F; Di Russo A; Citterio D; Mazzaferro V; Cosimelli M
Dig Liver Dis; 2021 Aug; 53(8):1041-1047. PubMed ID: 33487580
[TBL] [Abstract][Full Text] [Related]
12. Surgery Versus Chemotherapy and Radiotherapy For Early and Locally Advanced Small Cell Lung Cancer: A Propensity-Matched Analysis of Survival.
Wakeam E; Acuna SA; Leighl NB; Giuliani ME; Finlayson SRG; Varghese TK; Darling GE
Lung Cancer; 2017 Jul; 109():78-88. PubMed ID: 28577955
[TBL] [Abstract][Full Text] [Related]
13. Survival Outcomes After Surgical Management of the Primary Tumor With and Without Radiotherapy for Metastatic Rectal Adenocarcinoma: A National Cancer Database (NCDB) Analysis.
Renz P; Wegner RE; Hasan S; Brookover R; Finley G; Monga D; Raj M; McCormick J; Kirichenko A
Clin Colorectal Cancer; 2019 Jun; 18(2):e237-e243. PubMed ID: 30905549
[TBL] [Abstract][Full Text] [Related]
14. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.
Renehan AG; Malcomson L; Emsley R; Gollins S; Maw A; Myint AS; Rooney PS; Susnerwala S; Blower A; Saunders MP; Wilson MS; Scott N; O'Dwyer ST
Lancet Oncol; 2016 Feb; 17(2):174-183. PubMed ID: 26705854
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database.
Ecker BL; McMillan MT; Datta J; Lee MK; Karakousis GC; Vollmer CM; Drebin JA; Fraker DL; Roses RE
Cancer; 2017 May; 123(6):967-976. PubMed ID: 28263387
[TBL] [Abstract][Full Text] [Related]
16. Survival benefit from immunocheckpoint inhibitors in stage IV non-small cell lung cancer patients with brain metastases: A National Cancer Database propensity-matched analysis.
Takamori S; Komiya T; Powell E
Cancer Med; 2021 Feb; 10(3):923-932. PubMed ID: 33340271
[TBL] [Abstract][Full Text] [Related]
17. Multicentre propensity score-matched analysis of laparoscopic versus open surgery for T4 rectal cancer.
de'Angelis N; Landi F; Vitali GC; Memeo R; Martínez-Pérez A; Solis A; Assalino M; Vallribera F; Mercoli HA; Marescaux J; Mutter D; Ris F; Espin E; Brunetti F
Surg Endosc; 2017 Aug; 31(8):3106-3121. PubMed ID: 27826780
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: A propensity score-matched analysis.
Ecker BL; McMillan MT; Datta J; Mamtani R; Giantonio BJ; Dempsey DT; Fraker DL; Drebin JA; Karakousis GC; Roses RE
Cancer; 2016 Mar; 122(5):693-701. PubMed ID: 26717303
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors of overall survival and cancer-specific survival in patients with resected early-stage rectal adenocarcinoma: a SEER-based study.
Lee KC; Chung KC; Chen HH; Liu CC; Lu CC
J Investig Med; 2017 Dec; 65(8):1148-1154. PubMed ID: 28735257
[TBL] [Abstract][Full Text] [Related]
20. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
